A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing
<p>Abstract</p> <p>C-Reactive Protein (CRP) is an acute phase reactant routinely used as a biomarker to assess either infection or inflammatory processes such as autoimmune diseases. CRP also has demonstrated utility as a predictive marker of future risk of cardiovascular disease....
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2008-04-01
|
| Series: | Journal of Nanobiotechnology |
| Online Access: | http://www.jnanobiotechnology.com/content/6/1/5 |
| _version_ | 1811184086339813376 |
|---|---|
| author | Cooper Matthew A McBride Jeffrey D |
| author_facet | Cooper Matthew A McBride Jeffrey D |
| author_sort | Cooper Matthew A |
| collection | DOAJ |
| description | <p>Abstract</p> <p>C-Reactive Protein (CRP) is an acute phase reactant routinely used as a biomarker to assess either infection or inflammatory processes such as autoimmune diseases. CRP also has demonstrated utility as a predictive marker of future risk of cardiovascular disease. A new method of immunoassay for the detection of C-Reactive Protein has been developed using Resonant Acoustic Profiling™ (RAP™) with comparable sensitivity to a high sensitivity CRP ELISA (hsCRP) but with considerable time efficiency (12 minutes turnaround time to result). In one method, standard solutions of CRP (0 to 231 ng/mL) or diluted spiked horse serum sample are injected through two sensor channels of a RAP™ biosensor. One contains a surface with sheep antibody to CRP, the other a control surface containing purified Sheep IgG. At the end of a 5-minute injection the initial rate of change in resonant frequency was proportional to CRP concentration. The initial rates of a second sandwich step of anti-CRP binding were also proportional to the sample CRP concentration and provided a more sensitive method for quantification of CRP. The lower limit of detection for the direct assay and the homogenous sandwich assay were both 20 ng/mL whereas for the direct sandwich assay the lower limit was 3 ng/mL. In a step towards a rapid clinical assay, diluted horse blood spiked with human CRP was passed over one sensor channel whilst a reference standard solution at the borderline cardiovascular risk level was passed over the other. A semi-quantities ratio was thus obtained indicative of sample CRP status. Overall, the present study revealed that CRP concentrations in serum that might be expected in both normal and pathological conditions can be detected in a time-efficient, label-free immunoassay with RAP™ detection technology with determined CRP concentrations in close agreement with those determined using a commercially available high sensitivity ELISA.</p> |
| first_indexed | 2024-04-11T13:07:10Z |
| format | Article |
| id | doaj.art-82b5eb4a4d44481a871eb2003ba15f93 |
| institution | Directory Open Access Journal |
| issn | 1477-3155 |
| language | English |
| last_indexed | 2024-04-11T13:07:10Z |
| publishDate | 2008-04-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Nanobiotechnology |
| spelling | doaj.art-82b5eb4a4d44481a871eb2003ba15f932022-12-22T04:22:41ZengBMCJournal of Nanobiotechnology1477-31552008-04-0161510.1186/1477-3155-6-5A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensingCooper Matthew AMcBride Jeffrey D<p>Abstract</p> <p>C-Reactive Protein (CRP) is an acute phase reactant routinely used as a biomarker to assess either infection or inflammatory processes such as autoimmune diseases. CRP also has demonstrated utility as a predictive marker of future risk of cardiovascular disease. A new method of immunoassay for the detection of C-Reactive Protein has been developed using Resonant Acoustic Profiling™ (RAP™) with comparable sensitivity to a high sensitivity CRP ELISA (hsCRP) but with considerable time efficiency (12 minutes turnaround time to result). In one method, standard solutions of CRP (0 to 231 ng/mL) or diluted spiked horse serum sample are injected through two sensor channels of a RAP™ biosensor. One contains a surface with sheep antibody to CRP, the other a control surface containing purified Sheep IgG. At the end of a 5-minute injection the initial rate of change in resonant frequency was proportional to CRP concentration. The initial rates of a second sandwich step of anti-CRP binding were also proportional to the sample CRP concentration and provided a more sensitive method for quantification of CRP. The lower limit of detection for the direct assay and the homogenous sandwich assay were both 20 ng/mL whereas for the direct sandwich assay the lower limit was 3 ng/mL. In a step towards a rapid clinical assay, diluted horse blood spiked with human CRP was passed over one sensor channel whilst a reference standard solution at the borderline cardiovascular risk level was passed over the other. A semi-quantities ratio was thus obtained indicative of sample CRP status. Overall, the present study revealed that CRP concentrations in serum that might be expected in both normal and pathological conditions can be detected in a time-efficient, label-free immunoassay with RAP™ detection technology with determined CRP concentrations in close agreement with those determined using a commercially available high sensitivity ELISA.</p>http://www.jnanobiotechnology.com/content/6/1/5 |
| spellingShingle | Cooper Matthew A McBride Jeffrey D A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing Journal of Nanobiotechnology |
| title | A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing |
| title_full | A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing |
| title_fullStr | A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing |
| title_full_unstemmed | A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing |
| title_short | A high sensitivity assay for the inflammatory marker C-Reactive protein employing acoustic biosensing |
| title_sort | high sensitivity assay for the inflammatory marker c reactive protein employing acoustic biosensing |
| url | http://www.jnanobiotechnology.com/content/6/1/5 |
| work_keys_str_mv | AT coopermatthewa ahighsensitivityassayfortheinflammatorymarkercreactiveproteinemployingacousticbiosensing AT mcbridejeffreyd ahighsensitivityassayfortheinflammatorymarkercreactiveproteinemployingacousticbiosensing AT coopermatthewa highsensitivityassayfortheinflammatorymarkercreactiveproteinemployingacousticbiosensing AT mcbridejeffreyd highsensitivityassayfortheinflammatorymarkercreactiveproteinemployingacousticbiosensing |